Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1347613/000110465918063974/a18-37215_18k.htm
March 2019
March 2019
March 2019
February 2019
February 2019
January 2019
January 2019
December 2018
December 2018
December 2018
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1347613/000110465918063974/a18-37215_18k.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Synergy Pharmaceuticals, Inc..
Synergy Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
Material Contracts, Statements, Certifications & more
Synergy Pharmaceuticals, Inc. provided additional information to their SEC Filing as exhibits
Ticker: SGYPEvents:
CIK: 1347613
Form Type: 8-K Corporate News
Accession Number: 0001104659-18-063974
Submitted to the SEC: Thu Oct 25 2018 5:18:32 PM EST
Accepted by the SEC: Thu Oct 25 2018
Period: Thursday, October 25, 2018
Industry: Pharmaceutical Preparations